These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37526237)

  • 1. Acute Exercise Effect on Neurocognitive Function Among Cognitively Normal Late-Middle-Aged Adults With/Without Genetic Risk of AD: The Moderating Role of Exercise Volume and APOE Genotype.
    Chang YK; Etnier JL; Li RH; Ren FF; Ai JY; Chu CH
    J Gerontol A Biol Sci Med Sci; 2024 Feb; 79(2):. PubMed ID: 37526237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
    Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
    Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of APOE ε4 genotype and lifestyle with cognitive function among Chinese adults aged 80 years and older: A cross-sectional study.
    Jin X; He W; Zhang Y; Gong E; Niu Z; Ji J; Li Y; Zeng Y; Yan LL
    PLoS Med; 2021 Jun; 18(6):e1003597. PubMed ID: 34061824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Apolipoprotein E ɛ4 Carrier Status on Cognitive Response to Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Cheng YC; Huang YC; Liu HC
    Dement Geriatr Cogn Disord; 2018; 45(5-6):335-352. PubMed ID: 30041236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of physical activity on cognition relative to APOE genotype (PAAD-2): study protocol for a phase II randomized control trial.
    Park KS; Ganesh AB; Berry NT; Mobley YP; Karper WB; Labban JD; Wahlheim CN; Williams TM; Wideman L; Etnier JL
    BMC Neurol; 2020 Jun; 20(1):231. PubMed ID: 32503473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations Between Sub-Threshold Amyloid-β Deposition, Cortical Volume, and Cognitive Function Modulated by APOE ɛ4 Carrier Status in Cognitively Normal Older Adults.
    Kang DW; Wang SM; Um YH; Kim NY; Lee CU; Lim HK
    J Alzheimers Dis; 2022; 89(3):1003-1016. PubMed ID: 35964194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOE Genotype Disclosure Influences Decisions About Future Planning but not Adoption of Healthy Lifestyle Changes in Cognitively Unimpaired Individuals.
    Popescu DL; Lee AK; Arthur E; Thompson LI; Alber J
    J Geriatr Psychiatry Neurol; 2024 Nov; 37(6):482-495. PubMed ID: 38459948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E ε4 allele impairs cortical activity in healthy aging and Alzheimer's disease.
    Pedroso RV; Fraga FJ; Nascimento CMC; Pott-Junior H; Cominetti MR
    Behav Brain Res; 2022 Feb; 420():113700. PubMed ID: 34871705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of the APOE genotype on brain function across the lifespan.
    Filippini N; Ebmeier KP; MacIntosh BJ; Trachtenberg AJ; Frisoni GB; Wilcock GK; Beckmann CF; Smith SM; Matthews PM; Mackay CE
    Neuroimage; 2011 Jan; 54(1):602-10. PubMed ID: 20705142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
    Wang X; Wang J; He Y; Li H; Yuan H; Evans A; Yu X; He Y; Wang H
    J Alzheimers Dis; 2015; 45(3):781-95. PubMed ID: 25624419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of a 16-week exercise program, APOE status, and age on executive function task performance: A randomized trial.
    Martin-Willett R; Morris B; Wilcox R; Giordano G; Andrews-Hanna J; Banich M; Bryan AB
    Exp Gerontol; 2021 Sep; 152():111431. PubMed ID: 34062261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
    De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
    J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
    Dunk MM; Driscoll I;
    J Alzheimers Dis; 2022; 85(4):1519-1528. PubMed ID: 34958023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
    Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW
    Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Physical Activity and Alzheimer's Disease (PAAD) Study: Cognitive outcomes.
    Etnier JL; Karper WB; Labban JD; Piepmeier AT; Shih CH; Dudley WN; Henrich VC; Wideman L
    Ann Behav Med; 2018 Feb; 52(2):175-185. PubMed ID: 29538632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.